Search Results - "Devens, B."

Refine Results
  1. 1

    A Pilot Trial Targeting the ICOS–ICOS‐L Pathway in Nonhuman Primate Kidney Transplantation by Lo, D. J., Anderson, D. J., Song, M., Leopardi, F., Farris, A. B., Strobert, E., Chapin, S., Devens, B., Karrer, E., Kirk, A. D.

    Published in American journal of transplantation (01-04-2015)
    “…Costimulation blockade with the B7‐CD28 pathway‐specific agent belatacept is now used in clinical kidney transplantation, but its efficacy remains imperfect…”
    Get full text
    Journal Article
  2. 2

    The immunosuppressant leflunomide inhibits lymphocyte progression through cell cycle by a novel mechanism by Cherwinski, H M, McCarley, D, Schatzman, R, Devens, B, Ransom, J T

    “…Leflunomide is a novel and effective immunosuppressant that holds promise as a therapeutic agent, but the mechanism of action is unknown. Here we provide…”
    Get more information
    Journal Article
  3. 3

    Polyamine depletion therapy in prostate cancer by Devens, B H, Weeks, R S, Burns, M R, Carlson, C L, Brawer, M K

    Published in Prostate cancer and prostatic diseases (01-12-2000)
    “…The prostate gland has among the highest level of polyamines in the body and prostate carcinomas have even greater elevated polyamine levels. These ubiquitous…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Novel Lysine–Spermine Conjugate Inhibits Polyamine Transport and Inhibits Cell Growth When Given with DFMO by Weeks, Reitha S., Vanderwerf, Scott M., Carlson, C.Lance, Burns, Mark R., O'Day, Christine L., Cai, Feng, Devens, Bruce H., Webb, Heather K.

    Published in Experimental cell research (25-11-2000)
    “…Polyamines are ubiquitous molecules with multiple intracellular functions. Cells tightly regulate their levels through feedback mechanisms affecting synthesis,…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Influence of dietary restriction and aging on natural killer cell activity in mice by Weindruch, R, Devens, BH, Raff, HV, Walford, RL

    Published in The Journal of immunology (1950) (01-02-1983)
    “…Natural killer cells (NK) are believed to defend against tumor growth. Because rodents subjected to dietary restriction without malnutrition live longer and…”
    Get full text
    Journal Article
  8. 8

    Involvement of two distinct regulatory T cell populations in the antigen-specific suppression of cytolytic T cell generation by Devens, BH, Koontz, AW, Kapp, JA, Pierce, CW, Webb, DR

    Published in The Journal of immunology (1950) (01-03-1991)
    “…Alloantigen-specific, radiation-resistant T cells generated in mixed-lymphocyte cultures inhibited the generation of allospecific CTL responses in vitro. This…”
    Get full text
    Journal Article
  9. 9

    Production of human-human hybridomas secreting antibody to sheep erythrocytes after in vitro immunization by Strike, LE, Devens, BH, Lundak, RL

    Published in The Journal of immunology (1950) (01-04-1984)
    “…This report describes the formation of human hybridomas after in vitro immunization of tonsillar lymphocytes and fusion of the stimulated lymphocytes with a…”
    Get full text
    Journal Article
  10. 10

    Antipeptide antibody specific for the N-terminal of soluble immune response suppressor neutralizes concanavalin A and IFN-induced suppressor cell activity in an in vitro cytotoxic T lymphocyte response by Devens, BH, Semenuk, G, Webb, DR

    Published in The Journal of immunology (1950) (01-11-1988)
    “…Soluble immune response suppressor (SIRS) is a nonspecific immunosuppressive lymphokine produced by Lyt-2+ lymphocytes after exposure to Con A, IFN-alpha, or…”
    Get full text
    Journal Article
  11. 11

    Transduction of the IFN-gamma signal for HLA-DR expression in the promonocytic line THP-1 involves a late-acting PKC activity by Gumina, R J, Freire-Moar, J, DeYoung, L, Webb, D R, Devens, B H

    Published in Cellular immunology (01-12-1991)
    “…Interferon gamma (IFN-gamma) is the most potent known lymphokine for activating macrophages and has been shown to induce expression of HLA-DR in THP-1 cells, a…”
    Get more information
    Journal Article
  12. 12

    Effects of subchronic treatment with O,O,S-trimethyl phosphorothioate on cellular and humoral immune response systems by Rodgers, K E, Imamura, T, Devens, B H

    Published in Toxicology and applied pharmacology (01-01-1985)
    “…The effect of a 14-day treatment with low doses of O,O,S-Trimethyl phosphorothioate (OOS-TMP), an impurity in technical malathion, on the generation of…”
    Get more information
    Journal Article
  13. 13

    Antipeptide antibody specific for the N-terminal of soluble immune response suppressor neutralizes concavalin A and IFN-induced suppressor cell activity in an in vitro cytotoxic T lymphocyte response by DEVENS, B. H, SEMENUK, G, WEBB, D. R

    Published in The Journal of immunology (1950) (1988)
    “…Soluble immune response suppressor (SIRS) is a nonspecific immunosuppressive lymphokine produced by Lyt-2 super(+) lymphocytes after exposure to Con A, IFN-…”
    Get full text
    Journal Article
  14. 14

    Putative N-terminal sequence of murine soluble immune response suppressor (SIRS): significant homology with short neurotoxin 1 by Webb, D R, Mensi, N, Freire-Moar, J, Schnaper, H W, Lewis, R V, Semenuk, G, Devens, B H, Koontz, A, Danho, W, Pan, Y C

    Published in International immunology (1990)
    “…Soluble immune response suppressor (SIRS) is a low-molecular-weight protein (approximately 10,000 daltons) produced by mitogen- or interferon-activated T…”
    Get more information
    Journal Article
  15. 15

    Investigations into the mechanism of immunosuppression caused by acute treatment with O,O,S-trimethyl phosphorothioate: generation of suppressive macrophages from treated animals by Rodgers, K E, Imamura, T, Devens, B H

    Published in Toxicology and applied pharmacology (01-04-1987)
    “…At concentrations normally found in the spleen, macrophages from animals treated with O,O,S-trimethyl phosphorothioate (OOS-TMP) for 24 hr were previously…”
    Get more information
    Journal Article
  16. 16

    Phenotypic Identification of Specific and Nonspecific Suppressor T-Cell Populations Involved in the in Vivo Response to Alloantigen by Devens, Bruce H., Webb, David R.

    Published in Cellular immunology (01-03-1995)
    “…The monoclonal antibody 984.D4.6 (ma984) has been previously shown to recognize antigen-specific suppressor T-cells in an in vitro alloantigenic…”
    Get full text
    Journal Article
  17. 17

    Organophosphorus pesticide immunotoxicity: effects of O,O,S-trimethyl phosphorothioate on cellular and humoral immune response systems by Rodgers, K E, Imamura, T, Devens, B H

    Published in Immunopharmacology (01-12-1986)
    “…The time course of immunosuppression induced by acute treatment with O,O,S-trimethyl phosphorothioate (OOS-TMP), an impurity in technical formulations of…”
    Get more information
    Journal Article
  18. 18
  19. 19

    A 69-kDa Membrane Protein Associated with Lipopolysaccharide (LPS)-Induced Signal Transduction in the Human Monocytic Cell Line THP-1 by Fukuse, Satoshi, Maeda, Toshiro, Webb, David R., Devens, Bruce H.

    Published in Cellular immunology (01-09-1995)
    “…Lipopolysaccharide (LPS) triggers a wide range of cellular responses in mammalian cells. Several proteins, including CD14, have been reported to possess LPS…”
    Get full text
    Journal Article
  20. 20

    Induction of murine fibrosarcomas by low dose treatment with 3-methylcholanthrene followed by promotion with 12-O-tetradecanoyl-phorbol-13-acetate by Devens, B H, Lundak, R L, Byus, C V

    Published in Cancer letters (01-01-1984)
    “…Repeated application of the tumor promoter 12-O-tetradecanoyl phorbol-13-acetate (TPA) to the skin of mice previously treated with an initiating dose of the…”
    Get more information
    Journal Article